Companies: 10,795·Total market cap: $144.5T
Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc.

EKSONASDAQHealthcare
$11.80
+$0.15(+1.29%)
Market Cap$28625502
P/E Ratio
52W High$13.5
52W Low$2.73
Overview

Ekso Bionics Holdings, Inc.(EKSO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · EKSO · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$12.80M$17.93M$18.28M$12.91M$11.25M
Cost of Revenue$5.95M$8.41M$9.20M$6.70M$4.50M
Gross Profit$6.84M$9.51M$9.08M$6.21M$6.75M
Gross Margin %(computed)53.48%53.06%49.67%48.13%60.01%
Operating Expenses
R&D Expenses$3.03M$3.87M$5.03M$3.63M$2.75M
G&A Expenses$9.99M$8.79M$10.69M$10.99M$10.52M
Total Operating Expenses$20.17M$19.97M$24.19M$21.77M$20.58M
Operating Income($13.33M)($10.46M)($15.11M)($15.56M)($13.83M)
Operating Margin %(computed)-104.12%-58.35%-82.67%-120.48%-122.96%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.31M$0.27M$0.30M$0.16M$0.11M
Income Before Tax($11.70M)($11.33M)($15.20M)($15.08M)($9.76M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($11.70M)($11.33M)($15.20M)($15.08M)($9.76M)
Net Margin %(computed)-91.37%-63.21%-83.14%-116.79%-86.82%
Per Share & EBITDA
EPS (Basic)$-4.91$-8.43$-16.44$-17.45$-12.01
Wtd Avg Shares2.43M1.34M0.92M0.86M0.81M
EBITDA($9.81M)($9.45M)($13.20M)($14.04M)($9.09M)
EBITDA Margin %(computed)-76.67%-52.74%-72.20%-108.71%-80.83%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Ekso Bionics Holdings, Inc.

关于Ekso Bionics Holdings, Inc.(EKSO)损益表

Ekso Bionics Holdings, Inc.(EKSO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,EKSO实现营收$0.01B,毛利润$0.01B(毛利率53.48%),净利润($0.01B)(净利率-91.37%)。

常见问题

EKSO · 4 问

Ekso Bionics Holdings, Inc.(EKSO)2025财年营收为$0.01B,同比down28.6%。

EKSO revenueEKSO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09